Does PARSACLISIB Cause Hypertensive cardiomyopathy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hypertensive cardiomyopathy have been filed in association with PARSACLISIB. This represents 6.8% of all adverse event reports for PARSACLISIB.
5
Reports of Hypertensive cardiomyopathy with PARSACLISIB
6.8%
of all PARSACLISIB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Hypertensive cardiomyopathy From PARSACLISIB?
Of the 5 reports, 5 (100.0%) required hospitalization.
Is Hypertensive cardiomyopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PARSACLISIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does PARSACLISIB Cause?
Off label use (23)
Disease progression (15)
Pyrexia (14)
Pneumonia (11)
Bronchitis (9)
Neutropenic sepsis (9)
Neutrophil count decreased (9)
Blood lactate dehydrogenase increased (8)
Neutropenia (8)
Hypokalaemia (7)
What Other Drugs Cause Hypertensive cardiomyopathy?
METHOTREXATE (20)
CYCLOSPORINE (19)
TOCILIZUMAB (18)
TOFACITINIB (18)
ANAKINRA (17)
CANAKINUMAB (17)
OMEPRAZOLE (16)
BENDAMUSTINE (15)
ESCITALOPRAM OXALATE (15)
OBINUTUZUMAB (15)